This study assesses genotypic and phenotypic profiles of probiotic strains, revealing resistance genes and safety implications.
Introduction Antimicrobial resistance (AMR) has emerged as a critical global public health concern, particularly with regard to microorganisms used as probiotics in both veterinary and human healthcare. The aim of this study was to characterize the phenotypic and genotypic resistance profiles of several industrially applied probiotic bacterial strains, with special emphasis on the presence of antimicrobial resistance genes (ARGs). Methods Five strains, Enterococcus faecium, Bacillus licheniformis, Bacillus subtilis, Lactobacillus rhamnosus , and Pediococcus acidilactici were analyzed. Minimum inhibitory concentration (MIC) testing revealed resistance in multiple strains to clinically relevant antibiotics such as gentamicin, amoxicillin, tylosin, and florfenicol. Results Whole-genome sequencing identified 27 distinct ARGs, primarily associated with efflux pumps and target protection or modification mechanisms. The Bacillus licheniformis strain harbored the most diverse ARG profile, whereas no resistance genes were detected in Pediococcus acidilactici . Discussion These findings highlight the necessity of integrating phenotypic and genotypic assessments for the safe application of probiotic strains in animals and potentially human use.
No takes yet. Share an insight, caveat, or question.
Kerek et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: